|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2010-6-2
|
|
pubmed:abstractText |
Psychotherapy-pharmacotherapy combinations are frequently recommended for the treatment of chronic depressive disorders. Our aim in this novel reanalysis of archival data was to identify patient subgroups on the basis of symptom trajectories and examine the clinical significance of the resultant classification on basis of differential treatment effects to psychotherapy (cognitive behavioral analysis system of psychotherapy), pharmacotherapy (nefazodone), and their combination.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1939-2117
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
78
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
409-19
|
|
pubmed:meshHeading |
pubmed-meshheading:20515216-Adult,
pubmed-meshheading:20515216-Antidepressive Agents, Second-Generation,
pubmed-meshheading:20515216-Chronic Disease,
pubmed-meshheading:20515216-Cognitive Therapy,
pubmed-meshheading:20515216-Combined Modality Therapy,
pubmed-meshheading:20515216-Depressive Disorder, Major,
pubmed-meshheading:20515216-Dysthymic Disorder,
pubmed-meshheading:20515216-Female,
pubmed-meshheading:20515216-Humans,
pubmed-meshheading:20515216-Male,
pubmed-meshheading:20515216-Middle Aged,
pubmed-meshheading:20515216-Models, Psychological,
pubmed-meshheading:20515216-Personality Inventory,
pubmed-meshheading:20515216-Psychometrics,
pubmed-meshheading:20515216-Recurrence,
pubmed-meshheading:20515216-Triazoles
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Differential effects of treatments for chronic depression: a latent growth model reanalysis.
|
|
pubmed:affiliation |
Department of Psychiatry, University of Pennsylvania Philadelphia, PA 19104, USA. niklaus.stulz@gmail.com
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
